X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3531) 3531
Publication (268) 268
Newsletter (65) 65
Book Review (27) 27
Newspaper Article (18) 18
Magazine Article (16) 16
Book Chapter (10) 10
Conference Proceeding (7) 7
Paper (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1767) 1767
humans (1532) 1532
index medicus (1335) 1335
male (1171) 1171
female (969) 969
pharmacology & pharmacy (948) 948
sphingosine - analogs & derivatives (718) 718
fingolimod hydrochloride (717) 717
rats (697) 697
propylene glycol (624) 624
propylene glycols - pharmacology (615) 615
mice (588) 588
propylene glycols - administration & dosage (547) 547
propylene glycols - therapeutic use (515) 515
propylene (444) 444
adult (427) 427
propylene-glycol (416) 416
fty720 (306) 306
middle aged (290) 290
drug delivery systems (280) 280
administration, cutaneous (279) 279
immunosuppressive agents - therapeutic use (266) 266
propylene glycols - adverse effects (261) 261
time factors (261) 261
solubility (259) 259
analysis (258) 258
sphingosine - pharmacology (253) 253
administration, oral (252) 252
sphingosine - therapeutic use (251) 251
dose-response relationship, drug (241) 241
drugs (226) 226
immunosuppressive agents - pharmacology (224) 224
propylene glycols (221) 221
propylene glycol - chemistry (219) 219
propylene glycols - chemistry (214) 214
in-vitro (207) 207
immunology (206) 206
clinical neurology (198) 198
chemistry, multidisciplinary (191) 191
toxicology (190) 190
permeability (189) 189
multiple sclerosis (187) 187
skin (185) 185
research (180) 180
in vitro techniques (179) 179
transplantation (172) 172
in-vivo (170) 170
sphingosine - administration & dosage (170) 170
administration, topical (169) 169
immunosuppressive agents - administration & dosage (169) 169
skin - metabolism (167) 167
phenylcarbamates (162) 162
skin absorption (162) 162
polyethylene glycols - chemistry (159) 159
pharmacokinetics (158) 158
rats, sprague-dawley (156) 156
drug-delivery (154) 154
disease models, animal (153) 153
propylene glycol - administration & dosage (153) 153
treatment outcome (153) 153
chemistry, medicinal (152) 152
chemistry, pharmaceutical (151) 151
fingolimod (150) 150
propylene glycols - pharmacokinetics (150) 150
vehicles (150) 150
toxicity (149) 149
mice, inbred c57bl (146) 146
surgery (146) 146
drug combinations (145) 145
nanoparticles (140) 140
adolescent (139) 139
rabbits (137) 137
skin absorption - drug effects (135) 135
aged (134) 134
multiple sclerosis - drug therapy (132) 132
article (128) 128
poly (127) 127
permeation (126) 126
felbamate (125) 125
propylene glycols - toxicity (125) 125
neurosciences (122) 122
health aspects (121) 121
polymers - chemistry (121) 121
delivery (120) 120
rats, wistar (117) 117
sphingosine 1-phosphate (114) 114
pharmacy (111) 111
pregnancy (111) 111
dermatology (110) 110
glycerol (110) 110
oral fingolimod (110) 110
biochemistry & molecular biology (109) 109
immunosuppressive agents - adverse effects (109) 109
drug therapy (108) 108
sphingosine - adverse effects (108) 108
biological availability (106) 106
particle size (106) 106
cancer (104) 104
swine (104) 104
drug carriers - chemistry (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3460) 3460
German (64) 64
French (18) 18
Japanese (17) 17
Spanish (16) 16
Chinese (15) 15
Italian (12) 12
Polish (10) 10
Hungarian (7) 7
Russian (5) 5
Dutch (4) 4
Czech (3) 3
Portuguese (3) 3
Swedish (3) 3
Danish (2) 2
Romanian (2) 2
Slovak (2) 2
Bulgarian (1) 1
Croatian (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 6, pp. 545 - 556
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2010, Volume 362, Issue 5, pp. 387 - 401
Journal Article
Journal Article
Journal Article
Clinical Neuropharmacology, ISSN 0362-5664, 03/2010, Volume 33, Issue 2, pp. 91 - 101
Fingolimod (FTY720) is a first-in-class orally bioavailable compound that has shown efficacy in advanced clinical trials for the treatment of multiple... 
Sphingosine 1-phosphate receptor modulator | Multiple sclerosis | Fingolimod | Sphingosine 1-phosphate | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | T-CELL SUBSETS | multiple sclerosis | sphingosine 1-phosphate receptor modulator | PROTEIN-COUPLED RECEPTORS | CLINICAL NEUROLOGY | IMMUNOMODULATORY DRUG FTY720 | SPHINGOSINE 1-PHOSPHATE RECEPTOR-1 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | fingolimod | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | INTRAMUSCULAR INTERFERON BETA-1A | sphingosine 1-phosphate | RAT CEREBROCORTICAL ASTROCYTES | 12-MONTH PHASE-III | Encephalomyelitis, Autoimmune, Experimental - metabolism | Sphingosine - adverse effects | Humans | Neuroglia - drug effects | Propylene Glycols - adverse effects | Sphingosine - administration & dosage | Neurons - drug effects | Receptors, Lysosphingolipid - metabolism | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Multiple Sclerosis - metabolism | Propylene Glycols - pharmacology | Administration, Oral | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Fingolimod Hydrochloride | Sphingosine - pharmacology | Models, Immunological | Sphingosine - analogs & derivatives | Animals | Propylene Glycols - administration & dosage | Immune System - drug effects | Lymphocytes - drug effects | Central Nervous System - drug effects | Receptors, Lysosphingolipid - agonists | Immunosuppressive Agents - adverse effects | Multiple Sclerosis - drug therapy
Journal Article
Annals of Neurology, ISSN 0364-5134, 03/2015, Volume 77, Issue 3, pp. 425 - 435
Journal Article
Journal Article
Journal Article